$150.50
0.220.15%
Últ. Act.: Oct 30, 11:44 AM
Belite Bio (BLTE) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | FY '22 |
|---|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||||
| Estimate | $-0.77 | $-0.63 | $-0.55 | $-0.51 | — |
| Actual | $-0.54 | $-0.45 | $-0.70 | $-0.65 | $-0.33 |
| Surprise | +29.9% | +28.6% | -27.3% | -27.5% | — |
| Revenue | |||||
| Estimate | — | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.76 | $-0.88 | $3.69 | $-0.47 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 12, 2026 | $-0.54 | $-0.77 | 29.9 % |
| Q1 | May 20, 2026 | $-0.45 | $-0.63 | 28.6 % |
| Q4 | Mar 2, 2026 | $-0.70 | $-0.55 | -27.3 % |
| Q3 | Nov 10, 2025 | $-0.65 | $-0.51 | -27.5 % |